What is Unlearn
Unlearn.ai is an AI-driven platform that accelerates clinical drug development by developing and deploying AI to eliminate trial and error in medicine. It uses AI to generate digital twins, which are comprehensive forecasts of a patient's future health, generated from extensive patient-level data from previous studies. The AI model is trained on patient-level data from previous studies and generates digital twins to predict patient outcomes, increasing power in clinical trials while adhering to regulatory guidelines. Ideal for healthcare professionals, researchers, and pharmaceutical companies seeking to revolutionize the future of medicine.
How to use Unlearn
Download the whitepaper and learn about digital twins and their enhancement of clinical trials, leveraging Unlearn's AI technology to accelerate clinical drug development.
Frequently Asked Questions
How does Unlearn's AI model generate digital twins?
Unlearn invents and deploys new types of generative models trained on patient-level data to create a comprehensive forecast of a patient's future health, which is referred to as their digital twin.
What is Unlearn's AI model trained on?
Unlearn's AI model is trained on extensive patient-level data from previous studies.
Can Unlearn's AI model make accurate predictions in clinical trials?
Yes, Unlearn's AI model can calculate prognostic scores for each patient in a randomized clinical trial using their digital twin, increasing power while adhering to regulatory guidance. """ }